期刊文献+

Ⅰb2~Ⅱb期宫颈鳞状细胞癌术前3种新辅助化疗的疗效比较 被引量:7

Comparison of therapeutic efficacy among 3 different regimens of neoadjuvant chemotherapy for FIGO stage Ⅰb2—Ⅱb cervical squamous carcinoma before operation
下载PDF
导出
摘要 目的比较应用3种新辅助化疗方法治疗Ⅰb2~Ⅱb期宫颈鳞状细胞癌的近期疗效。方法回顾性分析应用新辅助化疗方法治疗的50例Ⅰb2~Ⅱb期宫颈鳞状细胞癌患者,其中全身化疗组13例,单纯动脉化疗(TAC)组19例,动脉栓塞化疗(TACE)组18例。观察化疗后的肿瘤缓解情况、肿瘤缩小率及不良反应、术中出血以及术后标本提示的预后不良因素(包括脉管癌栓、盆腔淋巴结转移、宫旁浸润、阴道切缘阳性、卵巢转移)并进行统计学分析。结果TAC组和TACE组的肿瘤缓解情况、肿瘤缩小率和术中出血量均优于全身化疗组(P<0.05);TAC组和TACE组间差异无统计学意义。TACE组的脉管癌栓和淋巴结转移发生率低于另外2组,但差异无统计学意义。3组病例在宫旁浸润、阴道切缘阳性、卵巢转移等因素和化疗后不良反应方面差异无统计学意义。结论对于Ⅰb2~Ⅱb期宫颈鳞状细胞癌,术前TAC和TACE优于全身化疗。与TAC相比,TACE有望减少脉管癌栓、盆腔淋巴结转移等预后不良因素的发生。 Objective To compare the short-time effect of 3 different regimens of neoadjuvant chemotherapy(NACT) in patients with FIGO stage Ⅰb2—Ⅱb cervical squamous carcinoma.Methods A total of 50 patients with FIGO stage Ⅰb2—Ⅱb cervical squamous carcinoma were divided into 3 groups: systemic chemotherapy group(n=13),trans-arterial chemotherapy group(TAC,n=19),trans-arterial chemoembolization group(TACE,n=18).After 1—3 periods of NACT,all patients received surgical operation.Tumor response and reduction ratio after NACT,side effects,hemorrhage volume in surgery and bad prognostic factors(including intraluminal tumor thrombi,pelvic lymph node metastasis,parametrial involvement,positive surgical margin,ovary metastasis) of operation sample were statistically analyzed.Results Tumor response,reduction ratio and hemorrhage volume in surgery were significantly better in TAC group and TACE group than those in systemic chemotherapy group(P0.05),but no significant difference was found between TAC group and TACE group(P0.05).The incidence rate of intraluminal tumor thrombi and lymph node metastasis was lower in TACE group than in systemic chemotherapy group and TAC group,but there was no statistical difference.No difference of parametrial involvement,positive surgical margin,ovary metastasis and side effects was found among 3 groups.Conclusion For stage Ⅰb2—Ⅱb cervical squamous carcinoma,preoperative TAC and TACE have more advantages than systemic chemotherapy.In comparison with TAC,TACE is expected to reduce the incidence rate of bad prognostic factors such as intraluminal tumor thrombi and pelvic lymph node metastasis.
出处 《中国介入影像与治疗学》 CSCD 2010年第2期133-136,共4页 Chinese Journal of Interventional Imaging and Therapy
关键词 鳞状细胞 宫颈 新辅助化疗 Carcinoma squamous cell Cervix uteri Neoadjuvant chemotherapy
  • 相关文献

参考文献13

二级参考文献42

共引文献97

同被引文献73

  • 1关于中华放射学杂志出版2005年增刊的声明[J].中华放射学杂志,2005,39(9):931-931. 被引量:1
  • 2郭文波,杨建勇,陈伟,庄文权,姚书忠.子宫肌瘤栓塞中误栓卵巢支对卵巢功能的影响[J].中华放射学杂志,2005,39(9):934-937. 被引量:26
  • 3吴晶涛,赵永生,王田蔚,杨海山,安东洪.介入治疗对宫颈癌微血管密度的影响[J].中国临床医学影像杂志,2005,16(10):581-583. 被引量:6
  • 4郭文波,杨建勇,李丽娟,陈伟,庄文权,朱云晓.子宫肌瘤栓塞治疗的中长期临床观察[J].介入放射学杂志,2006,15(9):539-542. 被引量:9
  • 5中华医学会妇产科分会中华妇产科杂志编辑委员会.妇科常见肿瘤诊断与治疗规范(草案)[J].中华妇产科杂志,1998,(33):694.
  • 6Im SS, Monk BJ. New developments in the treatment of invasive cervical eaneer[J]. Obstet Gynecol Clin North Am, 2002,29(4): 659-672.
  • 7Symonds P. Chemoradiation: the new gold standard for non- surgical treatment of cervical cancer[J]. Clin Oncol(R Coil Radiol), 2002,14(3) :201-202.
  • 8Vagno G, Conmio G, Pignata S, etal. Cisplatin and vinorelbine as neoadjuvant chemotherapy in locally advanced cervical cancer: a phase study[J]. Lnt J Gynecol Cancer, 2003, 13(3):308-312.
  • 9Duenas GA, Lopez G CM, Mota A, etal. Neodadjuvant chemotherapy followed by surgery in locally advanced cervical carcinoma [J]. J Clin Oncol, 2002,20(12): 2908-2909.
  • 10Patrick Soulie, Melanie Heroult, Isabelle Bernard-Pierrot, etal. Correlation of elevated plasma levels of two structurally related growth factors, heparin affin regulatory peptide and midkine, in advanced solid tumor patients[J]. Cancer Detection and Prevention, 2004,28(5) :319-324.

引证文献7

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部